Digital 2026: When clinical intelligence moves from promise to pract... We are about to enter a new era of clinical intelligence. The era of "digital" as a separate activity in healthcare will begin to dissolve in 2026.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.